Results of Joint Research on Drug Development with Nanjing Medical University Published in a Leading International Journal

The application of a drug candidate for ALS treatment was issued as a patent

A paper on our phosphorylation analysis service was published in a leading international academic journal

Our Phosphorylation Analysis Service to Expand in the U.S.

SOCIUM Inc. and Huaxi Hospital of Sichuan University have decided to conduct an investigator-initiated clinical trial of SO-002, a drug candidate for the treatment of amyotrophic lateral sclerosis (ALS)

AI drug discovery venture that takes on the challenge of overcoming “unmet medical needs, SOCIUM Inc.’s paper was published in The Journal of Biomedical Research